Lipid Profile Response to Electroacupuncture Stimulation in Non Alcoholic Fatty Liver Patients
Sponsor
Ramy Salama Draz (Other)
Overall Status
Completed
CT.gov ID
NCT04046718
Collaborator
(none)
60
1
2
4.2
14.2
Study Details
Study Description
Brief Summary
sixty female patients suffering from non-alcoholic fatty liver disease were randomly divided into two equal groups group 1 received electroacupuncture stimulation for 6 weeks at special points of stimulation. group 2 was a control group that received nothing without any change in lifestyle and we assed the response of lipid profile post-treatment protocol in both groupes
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Study Type:
Interventional
Actual Enrollment
:
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
two group study, one is the study group and the other is a control grouptwo group study, one is the study group and the other is a control group
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Lipid Profile Response to Electroacupuncture
Actual Study Start Date
:
Aug 22, 2019
Actual Primary Completion Date
:
Nov 25, 2019
Actual Study Completion Date
:
Dec 29, 2019
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: electroacupuncture the study group received electroacupuncture stimulation at different points |
Device: electro-acupuncture stimulation
stimulation of acupoints of the liver meridian of lv3 lv14
|
No Intervention: control group a control group with no intervention |
Outcome Measures
Primary Outcome Measures
- tri-triglycerides (mg/dl) , total cholesterol (mg/dl) , HDL (mg/dl) , LDL (mg/dl) [6 weeks]
lowering of total lipid profile in study group
Secondary Outcome Measures
- weight (kg) , height (m), BMI (kg/m2) [1st week]
calculation of body mass index
Eligibility Criteria
Criteria
Ages Eligible for Study:
30 Years
to 55 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
non alcoholic fatty liver BMI 30-40
Exclusion Criteria:
- Patients with: (Hepatitis C & b any form of seizure
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | faculty of physical therapy Cairo university | Cairo | Egypt |
Sponsors and Collaborators
- Ramy Salama Draz
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
Responsible Party:
Ramy Salama Draz,
Principal Investigator,
Cairo University
ClinicalTrials.gov Identifier:
NCT04046718
Other Study ID Numbers:
- P.T.REC/012/001579_1
First Posted:
Aug 6, 2019
Last Update Posted:
Aug 6, 2021
Last Verified:
Aug 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: